These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12955785)

  • 1. Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients.
    Moretti R; Torre P; Antonello RM; Cazzato G; Griggio S; Bava A
    Am J Alzheimers Dis Other Demen; 2003; 18(4):205-14. PubMed ID: 12955785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease.
    Clark WS; Street JS; Feldman PD; Breier A
    J Clin Psychiatry; 2001 Jan; 62(1):34-40. PubMed ID: 11235926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.
    Cummings JL; Street J; Masterman D; Clark WS
    Dement Geriatr Cogn Disord; 2002; 13(2):67-73. PubMed ID: 11844887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine in dementia with Lewy bodies: a clinical study.
    Walker Z; Grace J; Overshot R; Satarasinghe S; Swan A; Katona CL; McKeith IG
    Int J Geriatr Psychiatry; 1999 Jun; 14(6):459-66. PubMed ID: 10398356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.
    Schatz RA
    Ann Pharmacother; 2003 Sep; 37(9):1321-4. PubMed ID: 12921516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine as a possible treatment for anxiety due to vascular dementia: an open study.
    Moretti R; Torre P; Antonello RM; Cattaruzza T; Cazzato G; Bava A
    Am J Alzheimers Dis Other Demen; 2004; 19(2):81-8. PubMed ID: 15106388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis.
    Mintzer J; Faison W; Street JS; Sutton VK; Breier A
    Int J Geriatr Psychiatry; 2001 Dec; 16 Suppl 1():S71-7. PubMed ID: 11748790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia.
    Street JS; Clark WS; Kadam DL; Mitan SJ; Juliar BE; Feldman PD; Breier A
    Int J Geriatr Psychiatry; 2001 Dec; 16 Suppl 1():S62-70. PubMed ID: 11748789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Psychotropic Medication on Cognition, Caregiver Burden, and Neuropsychiatric Symptoms in Alzheimer's Disease over 12 Months: Results from a Prospective Registry of Dementia in Austria (PRODEM).
    Pirker-Kees A; Dal-Bianco P; Schmidt R
    J Alzheimers Dis; 2019; 71(2):623-630. PubMed ID: 31424389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.
    Street JS; Clark WS; Gannon KS; Cummings JL; Bymaster FP; Tamura RN; Mitan SJ; Kadam DL; Sanger TM; Feldman PD; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2000 Oct; 57(10):968-76. PubMed ID: 11015815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease.
    De Deyn PP; Carrasco MM; Deberdt W; Jeandel C; Hay DP; Feldman PD; Young CA; Lehman DL; Breier A
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):115-26. PubMed ID: 14758577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients.
    Edell WS; Tunis SL
    Am J Geriatr Psychiatry; 2001; 9(3):289-97. PubMed ID: 11481138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine.
    Mulsant BH; Gharabawi GM; Bossie CA; Mao L; Martinez RA; Tune LE; Greenspan AJ; Bastean JN; Pollock BG
    J Clin Psychiatry; 2004 Dec; 65(12):1708-14. PubMed ID: 15641877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine in whole, not half, tablets for psychosis from Alzheimer's dementia.
    Wolfgang SA
    Am J Health Syst Pharm; 1999 Nov; 56(21):2245-6. PubMed ID: 10565707
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine for psychosis in patients with Parkinson's disease with and without dementia.
    Aarsland D; Larsen JP; Lim NG; Tandberg E
    J Neuropsychiatry Clin Neurosci; 1999; 11(3):392-4. PubMed ID: 10440017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia.
    Reeves RR; Torres RA
    South Med J; 2003 Jul; 96(7):699-701. PubMed ID: 12940325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delusions in dementia: a review.
    Flint AJ
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):121-30. PubMed ID: 1687962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities.
    Fontaine CS; Hynan LS; Koch K; Martin-Cook K; Svetlik D; Weiner MF
    J Clin Psychiatry; 2003 Jun; 64(6):726-30. PubMed ID: 12823090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.
    Martin H; Slyk MP; Deymann S; Cornacchione MJ
    J Am Med Dir Assoc; 2003; 4(4):183-8. PubMed ID: 12837138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.